Given my brain MRI with and without contrast showing periventricular white‑matter changes, a history of hypertension treated with amlodipine, an estimated glomerular filtration rate of 92–93 mL/min/1.73 m², and normal calcium, vitamin D, and albumin (4.5–4.6 g/dL), what is the most likely cause of the white‑matter findings and how should I manage them?

Periventricular White Matter Changes in Hypertension with Preserved Kidney Function

Your periventricular white matter changes are most likely caused by your hypertension, and the primary management is optimizing blood pressure control to a target of <130/80 mmHg with your current amlodipine therapy, while monitoring for progression.

Understanding Your White Matter Changes

Your brain MRI findings represent hypertensive cerebral small vessel disease. With an eGFR of 92-93 mL/min/1.73 m², your kidney function is essentially normal (Stage 1-2 CKD at most), which actually makes hypertension the dominant driver of your white matter pathology 1, 2.

Why Hypertension Causes These Changes

• Periventricular white matter is particularly vulnerable to blood pressure fluctuations because these regions have watershed blood supply 2
• Chronic hypertension causes endothelial dysfunction, blood-brain barrier disruption, and neurovascular inflammation—all present even before white matter hyperintensities become visible on MRI 2
• The damage occurs through loss of cerebrovascular autoregulation, where blood pressure surges cause vasogenic edema in vulnerable periventricular regions 3

Your Kidney Function Context

Your eGFR of 92-93 is reassuring. While research shows that declining kidney function correlates with worse periventricular white matter disease 1, 4, 5, your preserved kidney function means:

• Hypertension is your primary modifiable risk factor 1
• The white matter changes are not being driven by uremic toxins or advanced CKD-related vascular damage
• You have an excellent opportunity to prevent progression through blood pressure control alone

Blood Pressure Management Strategy

Target Blood Pressure

Aim for <130/80 mmHg 6, 7. This is the guideline-recommended target for patients with hypertension and evidence of target organ damage (which your white matter changes represent) 7.

Your Current Amlodipine Therapy

Amlodipine is appropriate for your situation 8:

• Usual effective dose is 5-10 mg daily 8
• If you're on 5 mg and not at target, increase to 10 mg 8
• Amlodipine specifically increases glomerular filtration rate and renal plasma flow without causing proteinuria—beneficial given your normal kidney function 8
• Maximum antihypertensive effect takes 7-14 days after dose adjustment 8

If Blood Pressure Remains Uncontrolled

Add a renin-angiotensin system (RAS) blocker (ACE inhibitor or ARB) as second-line therapy 7. This combination:

• Provides complementary mechanisms of blood pressure reduction
• Offers additional cerebrovascular protection
• Is the preferred dual-agent strategy in hypertension guidelines 7

Monitoring Strategy

Blood Pressure Monitoring

Use home blood pressure monitoring (HBPM) to ensure you're truly controlled 6:

• Office readings may not reflect your true blood pressure (white coat effect)
• HBPM readings between 120-129 systolic or 75-79 diastolic warrant screening for masked hypertension 6
• Nighttime blood pressure is particularly important for cerebrovascular risk—consider 24-hour ambulatory monitoring if home readings are borderline 6

Follow-up MRI

Repeat brain MRI in 1-2 years to assess for:

• Progression of white matter changes (which would indicate inadequate blood pressure control)
• Stability or improvement (achievable with good control, as demonstrated in reversible cases 3)
• New lesions or microbleeds

Kidney Function Monitoring

Continue monitoring eGFR and albumin annually:

• Your current albumin of 4.5-4.6 g/dL is normal serum albumin
• Ensure urine albumin-to-creatinine ratio is also checked—this is different and critical for detecting early kidney damage 7
• Even mildly elevated urine albumin predicts worse white matter disease progression 5

Critical Pitfalls to Avoid

1. Don't assume office blood pressure tells the whole story—up to 30% of patients have masked hypertension where office readings are normal but home/ambulatory readings are elevated 6

2. Don't accept "borderline" blood pressure control—even modest elevations above 130/80 mmHg continue to drive white matter progression 1, 2

3. Don't overlook diastolic blood pressure—research specifically shows diastolic pressure correlates more strongly with periventricular white matter changes than systolic pressure in some populations 1

4. Don't delay treatment intensification—white matter damage begins in normal-appearing white matter before becoming visible on MRI 2, meaning early aggressive control prevents future damage

Additional Considerations

Your normal calcium and vitamin D levels are appropriate to maintain, as vitamin D deficiency may worsen vascular health in hypertension 9. Continue monitoring these as part of routine care.

The good news: Your white matter changes are potentially reversible or at least stabilizable with excellent blood pressure control, as demonstrated in case reports of hypertensive patients whose white matter hyperintensities improved after initiating antihypertensive therapy 3.